Nanjing Leads Biolabs | ApexOnco - Clinical Trials news and analysis

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Conferences

3 April 2025

Data insights

14 October 2024

Regulatory

7 May 2024

Trial results

29 February 2024

Trial results

31 January 2024

The company’s move could be a warning for rivals including GSK, AstraZeneca and Incyte.

Recent Quick take